Novartis today announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level. The oral suspension lots are being recalled because of a risk of potential peanut flour contamination that occurred at a third-party contract manufacturing site. (US Food Recalls) More
Novartis has issued a voluntary recall of 3 lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level, due to a risk of potential peanut ...
Posted on 13 May 2019 | 2:00 am | Google News
May 11 (Reuters) - Novartis AG: * ISSUES VOLUNTARY NATIONWIDE RECALL OF PROMACTA® 12.5 MG FOR ORAL SUSPENSION DUE TO POTENTIAL ...
Posted on 11 May 2019 | 4:50 pm | Google News
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public *service*. FDA does not endorse ...
Posted on 11 May 2019 | 2:00 am | Google News
Copyright © 2019 LastMinuteStuff.com